96 related articles for article (PubMed ID: 26428948)
1. Measuring depression in prostate cancer patients: does the scale used make a difference?
Sharpley CF; Bitsika V; Christie DR; Hunter MS
Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26428948
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing 'male' depression in men diagnosed with prostate cancer: the next step in effective translational psycho-oncology interventions?
Sharpley CF; Bitsika V; Christie DR
Psychooncology; 2014 Sep; 23(9):1042-8. PubMed ID: 24700681
[TBL] [Abstract][Full Text] [Related]
3. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care.
Cameron IM; Crawford JR; Lawton K; Reid IC
Br J Gen Pract; 2008 Jan; 58(546):32-6. PubMed ID: 18186994
[TBL] [Abstract][Full Text] [Related]
4. Do prostate cancer patients suffer more from depressed mood or anhedonia?
Sharpley CF; Bitsika V; Christie DH
Psychooncology; 2013 Aug; 22(8):1718-23. PubMed ID: 23019092
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two self-rating scales to detect depression: HADS and PHQ-9.
Hansson M; Chotai J; Nordstöm A; Bodlund O
Br J Gen Pract; 2009 Sep; 59(566):e283-8. PubMed ID: 19761655
[TBL] [Abstract][Full Text] [Related]
6. Depression rating scales in Parkinson's disease: critique and recommendations.
Schrag A; Barone P; Brown RG; Leentjens AF; McDonald WM; Starkstein S; Weintraub D; Poewe W; Rascol O; Sampaio C; Stebbins GT; Goetz CG
Mov Disord; 2007 Jun; 22(8):1077-92. PubMed ID: 17394234
[TBL] [Abstract][Full Text] [Related]
7. Differential item functioning of the HADS and PHQ-9: an investigation of age, gender and educational background in a clinical UK primary care sample.
Cameron IM; Crawford JR; Lawton K; Reid IC
J Affect Disord; 2013 May; 147(1-3):262-8. PubMed ID: 23218250
[TBL] [Abstract][Full Text] [Related]
8. How can we use depression severity to guide treatment selection when measures of depression categorize patients differently?
Zimmerman M; Martinez JH; Friedman M; Boerescu DA; Attiullah N; Toba C
J Clin Psychiatry; 2012 Oct; 73(10):1287-91. PubMed ID: 23058983
[TBL] [Abstract][Full Text] [Related]
9. Differences in major depressive disorder and generalised anxiety disorder symptomatology between prostate cancer patients receiving hormone therapy and those who are not.
Sharpley CF; Bitsika V; Wootten AC; Christie DR
Psychooncology; 2014 Dec; 23(12):1350-5. PubMed ID: 24789575
[TBL] [Abstract][Full Text] [Related]
10. Making Sense of Variations in Prevalence Estimates of Depression in Cancer: A Co-Calibration of Commonly Used Depression Scales Using Rasch Analysis.
Lambert SD; Clover K; Pallant JF; Britton B; King MT; Mitchell AJ; Carter G
J Natl Compr Canc Netw; 2015 Oct; 13(10):1203-11. PubMed ID: 26483060
[TBL] [Abstract][Full Text] [Related]
11. [The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients].
Krespi Boothby MR; Hill J; Holcombe C; Clark L; Fisher J; Salmon P
Turk Psikiyatri Derg; 2010; 21(1):49-59. PubMed ID: 20204904
[TBL] [Abstract][Full Text] [Related]
12. The cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episode.
Hung CI; Liu CY; Wang SJ; Yao YC; Yang CH
Int J Psychiatry Clin Pract; 2012 Mar; 16(1):33-40. PubMed ID: 22122659
[TBL] [Abstract][Full Text] [Related]
13. Identification of depression in diabetes: the efficacy of PHQ-9 and HADS-D.
Reddy P; Philpot B; Ford D; Dunbar JA
Br J Gen Pract; 2010 Jun; 60(575):e239-45. PubMed ID: 20529487
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the hospital anxiety and depression scale and the center for epidemiological studies depression scale for detecting depression in women with breast or gynecologic cancer.
Stafford L; Judd F; Gibson P; Komiti A; Quinn M; Mann GB
Gen Hosp Psychiatry; 2014; 36(1):74-80. PubMed ID: 24200105
[TBL] [Abstract][Full Text] [Related]
15. Factor structure of a combined measure of major depressive disorder and male depression in prostate cancer patients.
Sharpley CF; Bitsika V; Christie DR
Psychooncology; 2016 Apr; 25(4):475-7. PubMed ID: 26228568
[No Abstract] [Full Text] [Related]
16. Validity of the Hospital Anxiety and Depression Scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV.
Whelan-Goodinson R; Ponsford J; Schönberger M
J Affect Disord; 2009 Apr; 114(1-3):94-102. PubMed ID: 18656266
[TBL] [Abstract][Full Text] [Related]
17. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice.
Olssøn I; Mykletun A; Dahl AA
BMC Psychiatry; 2005 Dec; 5():46. PubMed ID: 16351733
[TBL] [Abstract][Full Text] [Related]
18. Validity of four screening scales for major depression in MS.
Patten SB; Burton JM; Fiest KM; Wiebe S; Bulloch AG; Koch M; Dobson KS; Metz LM; Maxwell CJ; Jetté N
Mult Scler; 2015 Jul; 21(8):1064-71. PubMed ID: 25583846
[TBL] [Abstract][Full Text] [Related]
19. Screening for major depressive disorder in adults with cerebral glioma: an initial validation of 3 self-report instruments.
Rooney AG; McNamara S; Mackinnon M; Fraser M; Rampling R; Carson A; Grant R
Neuro Oncol; 2013 Jan; 15(1):122-9. PubMed ID: 23229997
[TBL] [Abstract][Full Text] [Related]
20. Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson's disease.
Chagas MH; Tumas V; Rodrigues GR; Machado-de-Sousa JP; Filho AS; Hallak JE; Crippa JA
Age Ageing; 2013 Sep; 42(5):645-9. PubMed ID: 23761457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
